Oscar Health (OSCR) insider files Form 144 to sell 2,123 Class A shares

Rhea-AI Filing Summary

Oscar Health (OSCR) filed a notice that an affiliated holder plans to sell Class A common stock under Rule 144. The filing reports an intended sale of 2,123 Class A shares through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $35,517.79 at the time of the notice. The issuer had 229,010,000 shares outstanding of this class, giving context to the size of the planned sale.

The shares to be sold come from restricted stock units that vested under a registered plan on 12/01/2025, with a total of 5,118 shares acquired on that date as consideration for services rendered. The signer represents that they are not aware of any non-public material adverse information about Oscar Health’s current or future operations, consistent with Rule 144 requirements.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A Common Stock	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza, 8th Floor New York NY 10004	2123	35517.79	229010000	12/02/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A Common Stock	12/01/2025	Restricted stock units vesting under a registered plan	Issuer			5118	12/01/2025	Services Rendered

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Oscar Health (OSCR) disclose in this Form 144 filing?

The filing discloses that an affiliated holder plans to sell 2,123 shares of Oscar Health Class A common stock on the NYSE, with an aggregate market value of $35,517.79 at the time of the notice.

What type of Oscar Health (OSCR) securities are being sold and through which broker?

The planned sale involves Class A common stock of Oscar Health, to be executed through Morgan Stanley Smith Barney LLC on the NYSE.

How many Oscar Health (OSCR) shares are outstanding compared to the amount being sold?

The notice states that 229,010,000 shares of the relevant class were outstanding, compared with 2,123 shares covered by this proposed sale.

How were the Oscar Health (OSCR) shares being sold originally acquired?

The securities come from restricted stock units that vested under a registered plan on 12/01/2025, with 5,118 shares acquired as compensation for services rendered.

When is the approximate date of sale for the Oscar Health (OSCR) shares in this notice?

The notice lists an approximate date of sale of 12/02/2025 for the 2,123 Class A shares to be sold on the NYSE.

What representation does the seller make about non-public information on Oscar Health (OSCR)?

The seller represents that they do not know any material adverse information about Oscar Health’s current or prospective operations that has not been publicly disclosed, as required in the notice.